Fountain Valley, CA2 Active Studies

Tardive Dyskinesia Clinical Trials in Fountain Valley, CA

Find 2 actively recruiting tardive dyskinesia clinical trials in Fountain Valley, CA. Connect with local research sites and explore new treatment options.

2
Active Trials
1
Sponsors
150
Enrolling

Recruiting Tardive Dyskinesia Studies in Fountain Valley

About Tardive Dyskinesia Clinical Trials in Fountain Valley

Tardive dyskinesia is a neurological disorder characterized by involuntary, repetitive movements, especially of the face and tongue, caused by long-term use of certain psychiatric medications. It can be socially disabling and persistent. Treatment includes VMAT2 inhibitors (valbenazine, deutetrabenazine).

There are currently 2 tardive dyskinesia clinical trials recruiting participants in Fountain Valley, CA. These studies are seeking a combined 150 participants. Research is being sponsored by Neurocrine Biosciences. Clinical trial participation is free and participants receive study-related medical care at no cost.

Tardive Dyskinesia Clinical Trials in Fountain Valley — FAQ

Are there tardive dyskinesia clinical trials in Fountain Valley?

Yes, there are 2 tardive dyskinesia clinical trials currently recruiting in Fountain Valley, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Fountain Valley?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fountain Valley research site will contact you about next steps.

Are clinical trials in Fountain Valley free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fountain Valley studies also compensate for your time and travel.

What tardive dyskinesia treatments are being tested?

The 2 active trials in Fountain Valley are testing new therapies including novel drugs, biologics, and treatment approaches for tardive dyskinesia.

Data updated July 19, 2026 from ClinicalTrials.gov